228 related articles for article (PubMed ID: 24321187)
1. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
[TBL] [Abstract][Full Text] [Related]
2. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
Oyabu Y
Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase].
Koga H; Tomono K; Hirakata Y; Kohno S; Abe K; Kawamoto S; Kusano S; Tanaka K; Morikawa N; Sugiyama H; Katsumata T; Sasayama K; Shimoguchi K; Hashimoto A; Matsumoto Y; Inoue Y; Ishiguro M; Hori H; Mashimoto H; Dotsu Y; Tanaka H; Imamura Y; Kanda T; Hara K
Jpn J Antibiot; 1996 Aug; 49(8):800-7. PubMed ID: 9053534
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798
[TBL] [Abstract][Full Text] [Related]
7. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
8. Use of cefoperazone/sulbactam in neonates.
Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
[TBL] [Abstract][Full Text] [Related]
9. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
[TBL] [Abstract][Full Text] [Related]
10. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
[TBL] [Abstract][Full Text] [Related]
11. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital.
Koomanachai P; Tongsai S; Thamlikitkul V
J Med Assoc Thai; 2016 Jan; 99(1):8-14. PubMed ID: 27455819
[TBL] [Abstract][Full Text] [Related]
14. An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Bodey GP; Elting LS; Narro J; Koller C; O'Brien S; Estey E; Benjamin R
J Antimicrob Chemother; 1993 Jul; 32(1):141-52. PubMed ID: 8226405
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Winston DJ; Bartoni K; Bruckner DA; Schiller GJ; Territo MC
Clin Infect Dis; 1998 Mar; 26(3):576-83. PubMed ID: 9524826
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Kochhar P; Suvarna V; Duttagupta S; Sarkar S
Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
[TBL] [Abstract][Full Text] [Related]
17. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin-sulbactam versus piperacillin-tazobactam: a multicentre, randomised, single-blind, controlled clinical trial.
Zhiyong Z; Xiaoju L; Yanbin L; Yao Y; Rujia Y; Xueqin F; Wenxiang H; Sufang C; Zebo Y; Xingping Z; Minggang D; Peiyuan X; Weiming Z; Xianghui J; Hongwen Z; Yongchuan C; Fei Y; Zongzan N
Int J Antimicrob Agents; 2005 Jul; 26(1):22-7. PubMed ID: 15885986
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
20. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
